ZBIO 24.21 ▼ -10.30% Live Trading Data - Stocknear

Zenas BioPharma Inc.

NASDAQ: ZBIO · Real-Time Price · USD
24.21
-2.78 (-10.30%)
At close: Oct 16, 2025, 3:59 PM
25.87
6.86%
After-hours: Oct 16, 2025, 06:23 PM EDT
-10.30%
Bid 23
Market Cap 1.02B
Revenue (ttm) 15M
Net Income (ttm) -176.97M
EPS (ttm) -12.29
PE Ratio (ttm) -1.97
Forward PE -5.88
Analyst Buy
Dividends n/a
Ask 28.69
Volume 574,391
Avg. Volume (20D) 250,118
Open 27.41
Previous Close 26.99
Day's Range 23.81 - 27.50
52-Week Range 5.83 - 29.73
Beta -1.68
Ex-Dividend Date n/a

About ZBIO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZBIO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ZBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Zenas BioPharma Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+24.22%
ZBIO stock has given up its prior gain. Zenas BioP... Unlock content with Pro Subscription
1 week ago
+24.22%
Zenas BioPharma shares are trading higher after the company announced it secured global rights to InnoCare's orelabrutinib.